Sun Pharmaceutical Industries announced to close a strategic marketing partnership with US-based drug multinational Merck and Company Inc. in the domestic market which has reported gains for Sun Pharmaceutical Industries. Its shares rose 1.27% to Rs. 447 at 9:38 IST.

Pharmaceutical major Sun Pharmaceutical has finally got some relief after Franklin Templeton has finally decided to withdraw the appeal against the company. Franklin Templeton was a co- appellant along with Israeli pharmaceutical major Taro Pharma against Sun Pharma.
